Literature DB >> 34340982

Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.

Michael Bonelli1, Daniel Aletaha2.   

Abstract

Entities:  

Keywords:  B-lymphocytes; COVID-19; rituximab

Year:  2021        PMID: 34340982     DOI: 10.1136/annrheumdis-2021-220997

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.

Authors:  Yusuke Ito; Akira Honda; Mineo Kurokawa
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-03-28

2.  Autoimmune diseases and vaccines against COVID-19. Decision-making in uncertain scenarios.

Authors:  Alberto E Calvo Elías; Lucía Pérez Casado; José Luis Callejas Rubio
Journal:  Med Clin (Engl Ed)       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.